Breast Cancer

The Efficacy and Safety of CDK4/6 Inhibitors
The Efficacy and Safety of CDK4/6 Inhibitors
BY PANELISTS: JOYCE OSHAUGHNESSY, MD, BAYLOR CHARLES A. SAMMONS CANCER CENTER; MICHAEL REFF, RPH, MBA NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION; SARA M. TOLANEY,
Roles of the Oncologist Versus Pharmacist
Roles of the Oncologist Versus Pharmacist
BY PANELISTS: JOYCE OSHAUGHNESSY, MD, BAYLOR CHARLES A. SAMMONS CANCER CENTER; MICHAEL REFF, RPH, MBA NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION; SARA M. TOLANEY,
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.